Lemonade, Inc. (LMND) as of March 31, 2026 presents a deeply negative liquidation recovery posture to equity. Total assets of $1,958M face total liabilities of $1,440M, leaving reported book equity of $518M. Under liquidation haircuts, recoverable asset value contracts sharply. Cash and restricted cash of $387M receives full or near-full recovery (~$387M). Investments of $751M (fixed income, AFS) are mark-to-market with $2.2M net unrealized loss and all investment grade; recovery approximates $731M face AFS fair value plus $20M short-term. Premiums receivable of $449M gross, $4.5M allowance, net $445M: at 90-95% recovery, yields ~$400-423M. Reinsurance recoverables on paid and unpaid losses total $146M; collectability depends on counterparty credit (majority rated A or better per filing), but reinsurance recoverables are soft assets in liquidation — apply ~70-80% recovery, yielding ~$100-116M. Prepaid reinsurance premiums of $124M would partially recover on contract termination, assume ~70%, ~$87M. PP&E net of $17M at 50-60% yields ~$8-10M. Intangible assets net excluding goodwill of $8M: zero recovery. Goodwill of $19M: zero recovery. Deferred policy acquisition costs of $14M: zero recovery. Other assets $44M: mixed; assume ~50%, ~$22M. Restricted cash $12M, restricted investments $82M: full to near-full recovery, ~$94M. Total estimated liquidation asset recovery: approximately $1.85-1.95B. Against liabilities held at face — unpaid loss reserve $309M, unearned premiums $614M (regulatory run-off obligations), funds held under reinsurance $152M, operating lease $21M, GC financing facility $180M, accrued liabilities $129M, ceded premiums payable $21M, other — total liabilities $1,440M — net estimated recovery to equity is marginally positive to modestly positive on paper, but the liability stack includes insurance-specific obligations (loss reserves, unearned premiums) that do not extinguish cleanly in a regulated carrier liquidation, and regulatory surplus requirements lock $356M of the $826M held in subsidiaries. The accumulated deficit stands at -$1,500M. Key changes since the prior 10-K (December 31, 2025): the GC financing facility grew materially, with $179.6M outstanding at Q1 2026 versus prior period borrowings under a facility expanded to $200M for 2026; loss reserves grew quarter-over-quarter driven by 23% customer growth and reduced reinsurance cession rate (20% effective vs. 55% prior program year), substantially increasing retained risk on the balance sheet. Unearned premiums of $614M represent the single largest balance sheet item and constitute both an asset (unexpired premium) and an obligation (unexpired coverage). Under regulatory liquidation, these obligations do not terminate at face and would require claims payment and runoff management. Filing discusses the captive reinsurance structure (Lemonade Re SPC, Cayman; XOL captive) in MD&A but these entities' standalone balance sheets are not separately disclosed in the 10-Q XBRL tagging.
▼ Community Notes